Balis, F.M., Lester, C.M., Chrousos, G.P., Heideman, R.L. & Poplack, D.G. (1987) Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia. Journal of Clinical Oncology, 5, 202–207.
Ballerini, P., Landman-Parker, J., Cayuela, J.M., Asnafi, V., Labopin, M., Gandemer, V., Perel, Y., Michel, G., Leblanc, T., Schmitt, C., Fasola, S., Hagemejier, A., Sigaux, F., Auclerc, M.F., Douay, L., Leverger, G. & Baruchel, A. (2008) Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica, 93, 1658–1665.
Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. & van't Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, 1783–1786.
Cave, H., Guidal, C., Rohrlich, P., Delfau, M.H., Broyart, A., Lescoeur, B., Rahimy, C., Fenneteau, O., Monplaisir, N., d'Auriol, L., Ellion, J., Vilmer, E. & Grandchamp, B. (1994) Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood, 83, 1892–1902.
Clappier, E., Collette, S., Grardel, N., Girard, S., Suarez, L., Brunie, G., Kaltenbach, S., Yakouben, K., Mazingue, F., Robert, A., Boutard, P., Plantaz, D., Rohrlich, P., van Vlierberghe, P., Preudhomme, C., Otten, J., Speleman, F., Dastugue, N., Suciu, S., Benoit, Y., Bertrand, Y. & Cave, H. (2010) NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia, 24, 2023–2031.
Clarke, M., Gaynon, P., Hann, I., Harrison, G., Masera, G., Peto, R. & Richards, S. (2003) CNS-directed therapy for childhood acute lymphoblastic leukemia: childhood ALL Collaborative Group overview of 43 randomized trials. Journal of Clinical Oncology, 21, 1798–1809.
Conter, V., Arico, M., Basso, G., Biondi, A., Barisone, E., Messina, C., Parasole, R., De Rossi, G., Locatelli, F., Pession, A., Santoro, N., Micalizzi, C., Citterio, M., Rizzari, C., Silvestri, D., Rondelli, R., Lo Nigro, L., Ziino, O., Testi, A.M., Masera, G. & Valsecchi, M.G. (2010) Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia, 24, 255–264.
De Moerloose, B., Suciu, S., Bertrand, Y., Mazingue, F., Robert, A., Uyttebroeck, A., Yakouben, K., Ferster, A., Margueritte, G., Lutz, P., Munzer, M., Sirvent, N., Norton, L., Boutard, P., Plantaz, D., Millot, F., Philippet, P., Baila, L., Benoit, Y. & Otten, J. (2010) Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. Blood, 116, 36–44.
Domenech, C., Suciu, S., De Moerloose, B., Mazingue, F., Plat, G., Ferster, A., Uyttebroeck, A., Sirvent, N., Lutz, P., Yakouben, K., Munzer, M., Rohrlich, P., Plantaz, D., Millot, F., Philippet, P., Dastugue, N., Girard, S., Cave, H., Benoit, Y. & Bertrandfor, Y. (2014) Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial. Haematologica, 99, 1220–1227.
Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., Benoit, Y., Robert, A., Manel, A.M., Vilmer, E., Otten, J. & Philippe, N. (2002) Comparison of Escherichia coli-asparaginase with Erwinia asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood, 99, 2734–2739.
Follin, C. & Erfurth, E.M. (2016) Long-term effect of cranial radiotherapy on pituitary-hypothalamus area in childhood acute lymphoblastic leukemia survivors. Current Treatment Options in Oncology, 17, 50.
Follin, C., Gabery, S., Petersen, A., Sundgren, P.C., Bjorkman-Burtcher, I., Latt, J., Mannfolk, P. & Erfurth, E.M. (2016) Associations between metabolic risk factors and the hypothalamic volume in childhood leukemia survivors treated with cranial radiotherapy. PLoS One, 11, e0147575.
van Grotel, M., Meijerink, J.P., Beverloo, H.B., Langerak, A.W., Buys-Gladdines, J.G., Schneider, P., Poulsen, T.S., den Boer, M.L., Horstmann, M., Kamps, W.A., Veerman, A.J., van Wering, E.R., van Noesel, M.M. & Pieters, R. (2006) The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica, 91, 1212–1221.
van Grotel, M., Meijerink, J.P., van Wering, E.R., Langerak, A.W., Beverloo, H.B., Buijs-Gladdines, J.G., Burger, N.B., Passier, M., van Lieshout, E.M., Kamps, W.A., Veerman, A.J., van Noesel, M.M. & Pieters, R. (2008) Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia, 22, 124–131.
Guidal, C., Vilmer, E., Grandchamp, B. & Cave, H. (2002) A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia. Leukemia, 16, 762–764.
Hunger, S.P., Lu, X., Devidas, M., Camitta, B.M., Gaynon, P.S., Winick, N.J., Reaman, G.H. & Carroll, W.L. (2012) Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. Journal of Clinical Oncology, 30, 1663–1669.
Ito, C., Evans, W.E., McNinch, L., Coustan-Smith, E., Mahmoud, H., Pui, C.H. & Campana, D. (1996) Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 14, 2370–2376.
Kamps, W.A., Bokkerink, J.P., Hakvoort-Cammel, F.G., Veerman, A.J., Weening, R.S., van Wering, E.R., van Weerden, J.F., Hermans, J., Slater, R., van den Berg, E., Kroes, W.G. & van der Does-van den Berg, A. (2002) BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia, 16, 1099–1111.
Kamps, W.A., van der Pal-de Bruin, K.M., Veerman, A.J., Fiocco, M., Bierings, M. & Pieters, R. (2010) Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia, 24, 309–319.
Kaspers, G.J., Veerman, A.J., Popp-Snijders, C., Lomecky, M., Van Zantwijk, C.H., Swinkels, L.M., Van Wering, E.R. & Pieters, R. (1996) Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Medical and Pediatric Oncology, 27, 114–121.
Kelly, M.J., Trikalinos, T.A., Dahabreh, I.J., Gianferante, M. & Parsons, S.K. (2014) Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: a systematic review and meta-analysis. American Journal of Hematology, 89, 992–997.
Kelly, M.J., Pauker, S.G. & Parsons, S.K. (2015) Using nonrandomized studies to inform complex clinical decisions: the thorny issue of cranial radiation therapy for T-cell acute lymphoblastic leukemia. Pediatric Blood & Cancer, 62, 790–797.
Matloub, Y., Lindemulder, S., Gaynon, P.S., Sather, H., La, M., Broxson, E., Yanofsky, R., Hutchinson, R., Heerema, N.A., Nachman, J., Blake, M., Wells, L.M., Sorrell, A.D., Masterson, M., Kelleher, J.F. & Stork, L.C. (2006) Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Blood, 108, 1165–1173.
Matloub, Y., Stork, L., Asselin, B., Hunger, S.P., Borowitz, M., Jones, T., Bostrom, B., Gastier-Foster, J.M., Heerema, N.A., Carroll, A., Winick, N., Carroll, W.L., Camitta, B., Devidas, M. & Gaynon, P.S. (2016) Outcome of children with standard-risk T-lineage acute lymphoblastic leukemia-comparison among different treatment strategies. Pediatric Blood & Cancer, 63, 255–261.
Millot, F., Suciu, S., Philippe, N., Benoit, Y., Mazingue, F., Uyttebroeck, A., Lutz, P., Mechinaud, F., Robert, A., Boutard, P., Marguerite, G., Ferster, A., Plouvier, E., Rialland, X., Behard, C., Plantaz, D., Dresse, M.F., Philippet, P., Norton, L., Thyss, A., Dastugue, N., Waterkeyn, C., Vilmer, E. & Otten, J. (2001) Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. Journal of Clinical Oncology, 19, 1935–1942.
Mitchell, C.D., Richards, S.M., Kinsey, S.E., Lilleyman, J., Vora, A. & Eden, T.O. (2005) Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. British Journal of Haematology, 129, 734–745.
Moghrabi, A., Levy, D.E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V.K., Lipshultz, S.E., Neuberg, D.S., Gelber, R.D., Cohen, H.J., Sallan, S.E. & Silverman, L.B. (2007) Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109, 896–904.
Mondelaers, V., Suciu, S., De Moerloose, B., Ferster, A., Mazingue, F., Plat, G., Yakouben, K., Uyttebroeck, A., Lutz, P., Costa, V., Sirvent, N., Plouvier, E., Munzer, M., Poiree, M., Minckes, O., Millot, F., Plantaz, D., Maes, P., Hoyoux, C., Cave, H., Rohrlich, P., Bertrand, Y. & Benoit, Y. (2017) Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951. Haematologica, 102, 1727–1738.
Moricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dordelmann, M., Loning, L., Beier, R., Ludwig, W.D., Ratei, R., Harbott, J., Boos, J., Mann, G., Niggli, F., Feldges, A., Henze, G., Welte, K., Beck, J.D., Klingebiel, T., Niemeyer, C., Zintl, F., Bode, U., Urban, C., Wehinger, H., Niethammer, D., Riehm, H. & Schrappe, M. (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111, 4477–4489.
Moricke, A., Zimmermann, M., Reiter, A., Henze, G., Schrauder, A., Gadner, H., Ludwig, W.D., Ritter, J., Harbott, J., Mann, G., Klingebiel, T., Zintl, F., Niemeyer, C., Kremens, B., Niggli, F., Niethammer, D., Welte, K., Stanulla, M., Odenwald, E., Riehm, H. & Schrappe, M. (2010) Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia, 24, 265–284.
Moricke, A., Zimmermann, M., Valsecchi, M.G., Stanulla, M., Biondi, A., Mann, G., Locatelli, F., Cazzaniga, G., Niggli, F., Arico, M., Bartram, C.R., Attarbaschi, A., Silvestri, D., Beier, R., Basso, G., Ratei, R., Kulozik, A.E., Lo Nigro, L., Kremens, B., Greiner, J., Parasole, R., Harbott, J., Caruso, R., von Stackelberg, A., Barisone, E., Rossig, C., Conter, V. & Schrappe, M. (2016) Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood, 127, 2101–2112.
Petit, A., Trinquand, A., Chevret, S., Ballerini, P., Cayuela, J.M., Grardel, N., Touzart, A., Brethon, B., Lapillonne, H., Schmitt, C., Thouvenin, S., Michel, G., Preudhomme, C., Soulier, J., Landman-Parker, J., Leverger, G., Macintyre, E., Baruchel, A. & Asnafi, V. (2018) Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia. Blood, 131, 289–300.
Pui, C.H., Campana, D., Pei, D., Bowman, W.P., Sandlund, J.T., Kaste, S.C., Ribeiro, R.C., Rubnitz, J.E., Raimondi, S.C., Onciu, M., Coustan-Smith, E., Kun, L.E., Jeha, S., Cheng, C., Howard, S.C., Simmons, V., Bayles, A., Metzger, M.L., Boyett, J.M., Leung, W., Handgretinger, R., Downing, J.R., Evans, W.E. & Relling, M.V. (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. New England Journal of Medicine, 360, 2730–2741.
Pui, C.H., Pei, D., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Raimondi, S.C., Onciu, M., Campana, D., Kun, L.E., Jeha, S., Cheng, C., Howard, S.C., Metzger, M.L., Bhojwani, D., Downing, J.R., Evans, W.E. & Relling, M.V. (2010) Long-term results of St Jude total therapy studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia, 24, 371–382.
Raetz, E.A. & Teachey, D.T. (2016) T-cell acute lymphoblastic leukemia. Hematology/the Education Program of the American Society of Hematology, 2016, 580–588.
Reismuller, B., Attarbaschi, A., Peters, C., Dworzak, M.N., Potschger, U., Urban, C., Fink, F.M., Meister, B., Schmitt, K., Dieckmann, K., Henze, G., Haas, O.A., Gadner, H. & Mann, G. (2009) Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria–a population-based report of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group. British Journal of Haematology, 144, 559–570.
Reismuller, B., Peters, C., Dworzak, M.N., Potschger, U., Urban, C., Meister, B., Schmitt, K., Dieckmann, K., Gadner, H., Attarbaschi, A. & Mann, G. (2013) Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Munster) study group. Journal of Pediatric Hematology/Oncology, 35, e200–e204.
Richards, S., Pui, C.H. & Gayon, P. (2013) Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer, 60, 185–195.
Salzer, W.L., Devidas, M., Carroll, W.L., Winick, N., Pullen, J., Hunger, S.P. & Camitta, B.A. (2010) Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group. Leukemia, 24, 355–370.
Schmiegelow, K., Forestier, E., Hellebostad, M., Heyman, M., Kristinsson, J., Soderhall, S. & Taskinen, M. (2010) Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia, 24, 345–354.
Schrappe, M., Valsecchi, M.G., Bartram, C.R., Schrauder, A., Panzer-Grumayer, R., Moricke, A., Parasole, R., Zimmermann, M., Dworzak, M., Buldini, B., Reiter, A., Basso, G., Klingebiel, T., Messina, C., Ratei, R., Cazzaniga, G., Koehler, R., Locatelli, F., Schafer, B.W., Arico, M., Welte, K., van Dongen, J.J., Gadner, H., Biondi, A. & Conter, V. (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118, 2077–2084.
Silverman, L.B., Stevenson, K.E., O'Brien, J.E., Asselin, B.L., Barr, R.D., Clavell, L., Cole, P.D., Kelly, K.M., Laverdiere, C., Michon, B., Schorin, M.A., Schwartz, C.L., O'Holleran, E.W., Neuberg, D.S., Cohen, H.J. & Sallan, S.E. (2010) Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia, 24, 320–334.
Sirvent, N., Suciu, S., Rialland, X., Millot, F., Benoit, Y., Plantaz, D., Ferster, A., Robert, A., Lutz, P., Nelken, B., Plouvier, E., Norton, L., Bertrand, Y. & Otten, J. (2011) Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881. European Journal of Cancer, 47, 239–247.
Taskinen, M., Oskarsson, T., Levinsen, M., Bottai, M., Hellebostad, M., Jonsson, O.G., Lahteenmaki, P., Schmiegelow, K. & Heyman, M. (2017) The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols. Pediatric Blood & Cancer, 64, 242–249.
Teuffel, O., Kuster, S.P., Hunger, S.P., Conter, V., Hitzler, J., Ethier, M.C., Shah, P.S., Beyene, J. & Sung, L. (2011) Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia, 25, 1232–1238.
Tsuchida, M., Ohara, A., Manabe, A., Kumagai, M., Shimada, H., Kikuchi, A., Mori, T., Saito, M., Akiyama, M., Fukushima, T., Koike, K., Shiobara, M., Ogawa, C., Kanazawa, T., Noguchi, Y., Oota, S., Okimoto, Y., Yabe, H., Kajiwara, M., Tomizawa, D., Ko, K., Sugita, K., Kaneko, T., Maeda, M., Inukai, T., Goto, H., Takahashi, H., Isoyama, K., Hayashi, Y., Hosoya, R. & Hanada, R. (2010) Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999. Leukemia, 24, 383–396.
Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cave, H., Thyss, A., Benoit, Y., Dastugue, N., Fournier, M., Souillet, G., Manel, A.M., Robert, A., Nelken, B., Millot, F., Lutz, P., Rialland, X., Mechinaud, F., Boutard, P., Behar, C., Chantraine, J.M., Plouvier, E., Laureys, G., Brock, P., Uyttebroeck, A., Margueritte, G., Plantaz, D., Norton, L., Francotte, N., Gyselinck, J., Waterkeyn, C., Solbu, G., Philippe, N. & Otten, J. (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia, 14, 2257–2266.
Vora, A., Andreano, A., Pui, C.H., Hunger, S.P., Schrappe, M., Moericke, A., Biondi, A., Escherich, G., Silverman, L.B., Goulden, N., Taskinen, M., Pieters, R., Horibe, K., Devidas, M., Locatelli, F. & Valsecchi, M.G. (2016) Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy. Journal of Clinical Oncology, 34, 919–926.
van der Werff Ten Bosch, J., Suciu, S., Thyss, A., Bertrand, Y., Norton, L., Mazingue, F., Uyttebroeck, A., Lutz, P., Robert, A., Boutard, P., Ferster, A., Plouvier, E., Maes, P., Munzer, M., Plantaz, D., Dresse, M.F., Philippet, P., Sirvent, N., Waterkeyn, C., Vilmer, E., Philippe, N. & Otten, J. (2005) Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia, 19, 721–726.
